Jon Olav Ødegård, CEO and primary insider in Hofseth BioCare ASA, has through his company Ødegård Prosjekt AS today, 28 August 2014 purchased 5,000 shares at NOK 3.75 per share.
After this transaction Mr. Ødegård controls through Ødegård Prosjekt AS, and indirectly through related parties in total 1,770,706 shares, representing 1.81% of the shares in Hofseth BioCare ASA.
This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.